{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:17:41Z","timestamp":1792513061010,"version":"4.5.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002490"],"award-info":[{"award-number":["KL2TR002490"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The goal of this study is to determine barriers and facilitators to the implementation of medication adherence interventions to support cancer patients taking novel, targeted oral anticancer agents (OAAs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted qualitative interviews using a semi-structured guide from the Consolidated Framework for Implementation Research (CFIR). We used purposive sampling to identify clinicians (physicians, pharmacists, nurse practitioners, nurses) and administrators (leadership from medicine, pharmacy, and nursing) who delivered care and\/or oversee care delivery for patients with chronic leukemia prescribed an OAA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 19 individuals participated in an interview (12 clinicians and 7 administrators), with 10 primarily employed by an academic cancer center; 5 employed by the community cancer center; and 4 employed by the integrated health-system specialty pharmacy. Barriers identified included low awareness of adherence interventions, difficulty in adherence measurement, complexity of designing and implementing a structured adherence intervention, and competing priorities. Facilitators identified included support of hospital administrators, value for pharmacists, and willingness to embrace change. Participants also made recommendations moving forward including standardizing workflow, designating champions, iterating implementation strategies, and improving communication between clinicians and with patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Individual and system level factors were identified as determinants of implementation effectiveness of medication adherence interventions. A multidisciplinary advisory panel will be assembled to design comprehensive and actionable strategies to refine and implement a structured intervention to improve medication adherence in cancer patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0286630","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T13:32:06Z","timestamp":1689946326000},"page":"e0286630","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2387-6676","authenticated-orcid":true,"given":"Benyam","family":"Muluneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-7863","authenticated-orcid":true,"given":"Michele A.","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Bernard","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrian","family":"Proco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Mackler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-1781","authenticated-orcid":true,"given":"Ashley","family":"Leak Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tilkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Gatwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah L.","family":"Zullig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8550-6195","authenticated-orcid":true,"given":"Jennifer","family":"Elston Lafata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"issue":"1\u20132","key":"pone.0286630.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000100444","article-title":"Adherence to endocrine therapy for breast cancer","volume":"71","author":"RT Chlebowski","year":"2006","journal-title":"Oncology"},{"issue":"14","key":"pone.0286630.ref002","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2009.26.3087","article-title":"Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib","volume":"28","author":"D Marin","year":"2010","journal-title":"J Clin Oncol"},{"issue":"19","key":"pone.0286630.ref003","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1182\/blood-2016-12-737346","article-title":"Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL\/SLL","volume":"129","author":"PM Barr","year":"2017","journal-title":"Blood"},{"issue":"2","key":"pone.0286630.ref004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41375-019-0699-y","article-title":"Do persons with chronic myeloid leukaemia have normal or near normal survival?","volume":"34","author":"T Radivoyevitch","year":"2020","journal-title":"Leukemia"},{"issue":"4","key":"pone.0286630.ref005","first-page":"279","article-title":"ONS Guidelines\u2122 to Support Patient Adherence to Oral Anticancer Medications.","volume":"49","author":"SM Belcher","year":"2022","journal-title":"Oncol Nurs Forum."},{"issue":"4","key":"pone.0286630.ref006","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1200\/JOP.18.00581","article-title":"2018 hematology\/oncology pharmacist association best practices for the management of oral oncolytic therapy: pharmacy practice standard","volume":"15","author":"E Mackler","year":"2019","journal-title":"J Oncol Pract"},{"issue":"6","key":"pone.0286630.ref007","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/OP.19.00668","article-title":"Patient-Centered Medically Integrated Dispensing: ASCO\/NCODA Standards Summary.","volume":"16","author":"MS Dillmon","year":"2020","journal-title":"JCO Oncol Pract."},{"issue":"6","key":"pone.0286630.ref008","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1200\/JOP.17.00039","article-title":"Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.","volume":"14","author":"B Muluneh","year":"2018","journal-title":"J Oncol Pract."},{"key":"pone.0286630.ref009","first-page":"2022:10781552211073576.","article-title":"Interpersonal communication-, education- and counselling-based interventions to support adherence to oral anticancer therapy: a systematic review","volume":"20","author":"J Elston Lafata","journal-title":"J Oncol Pharm Pract. Published online January"},{"issue":"1","key":"pone.0286630.ref010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/jamaoncol.2017.0625","article-title":"Interventions to improve oral chemotherapy safety and quality: A systematic review","volume":"4","author":"JA Zerillo","year":"2018","journal-title":"JAMA Oncol"},{"issue":"5","key":"pone.0286630.ref011","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jnci\/djz244","article-title":"Interventions to enhance adherence to oral antineoplastic agents: A scoping review","volume":"112","author":"SM Rosenberg","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"pone.0286630.ref012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fpubh.2019.00158","article-title":"Implementation mapping: using intervention mapping to develop implementation strategies.","volume":"7","author":"ME Fernandez","year":"2019","journal-title":"Front Public Health"},{"key":"pone.0286630.ref013","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"LJ Damschroder","year":"2009","journal-title":"Implement Sci"},{"key":"pone.0286630.ref014","volume-title":"Wiley Statsref: Statistics Reference Online","author":"TP Johnson","year":"2014"},{"issue":"6","key":"pone.0286630.ref015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.","volume":"19","author":"A Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"14","key":"pone.0286630.ref016","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/ajhp\/zxaa135","article-title":"Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.","volume":"77","author":"CC McCabe","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"pone.0286630.ref017","first-page":"148","article-title":"A Pharmacist-Led Oral Chemotherapy Program\u2019s Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes.","volume":"12","author":"T Dennison","year":"2021","journal-title":"J Adv Pract Oncol."},{"issue":"28_suppl","key":"pone.0286630.ref018","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1200\/JCO.2020.39.28_suppl.206","article-title":"A systematic approach to improving oral chemotherapy consent compliance in a rural cancer center","volume":"39","author":"P Benner","year":"2021","journal-title":"JCO"},{"issue":"34_suppl","key":"pone.0286630.ref019","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1200\/jco.2012.30.34_suppl.212","article-title":"Improving quality of pediatric oncology care via ASCO\u2019s Quality Oncology Practice Initiative (QOPI) program.","volume":"30","author":"RM Cooper","year":"2012","journal-title":"JCO."},{"issue":"30_suppl","key":"pone.0286630.ref020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2018.36.30_suppl.254","article-title":"Oral chemotherapy education sessions at an academic and community cancer center","volume":"36","author":"DA Roberts","year":"2018","journal-title":"JCO"},{"issue":"6","key":"pone.0286630.ref021","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/pbc.23078","article-title":"Disparities in cancer outcomes: lessons learned from children with cancer","volume":"56","author":"S. Bhatia","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"pone.0286630.ref022","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.2105\/AJPH.2014.302490","article-title":"Racial\/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.","volume":"1053","author":"MC Roberts","year":"2015","journal-title":"Am J Public Health"},{"issue":"3","key":"pone.0286630.ref023","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s11764-015-0499-y","article-title":"Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors","volume":"10","author":"M Lee","year":"2016","journal-title":"J Cancer Surviv"},{"issue":"4","key":"pone.0286630.ref024","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use.","volume":"5","author":"MJ Stirratt","year":"2015","journal-title":"Transl Behav Med"},{"issue":"11","key":"pone.0286630.ref025","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.clinthera.2009.11.030","article-title":"Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims.","volume":"31","author":"CA McHorney","year":"2009","journal-title":"Clin Ther."},{"issue":"4","key":"pone.0286630.ref026","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1474515119830298","article-title":"Improving medication adherence research reporting: ESPACOMP Medication Adherence Reporting Guideline (EMERGE).","volume":"18","author":"S De Geest","year":"2019","journal-title":"Eur J Cardiovasc Nurs."},{"issue":"7_suppl","key":"pone.0286630.ref027","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1200\/jco.2016.34.7_suppl.223","article-title":"Establishing an oncology quality dashboard for improvement","volume":"34","author":"D Denny","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0286630.ref028","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/21681805.2015.1063083","article-title":"Dashboard report on performance on select quality indicators to cancer care providers","volume":"50","author":"P Stattin","year":"2016","journal-title":"Scand J Urol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T13:32:31Z","timestamp":1689946351000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286630"}},"subtitle":[],"editor":[{"given":"Phyllis","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0286630","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}